moderna vaccine - Search News

News

Moderna, Influenza vaccine and Flu Shot

U.S. News & World Report · 2h

Moderna’s New Flu Shot Shows Strong Results in Older Adults

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA. Copyright © 2025 HealthDay. All rights reserved.

The Boston Globe · 23h

Moderna’s flu vaccine hits goal, paving way for combo shot

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Reuters on MSN · 1d

Moderna's influenza vaccine superior to licensed shot in study

Moderna said its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose seasonal flu shot in adults aged 50 years and older in a late-stage study. Shares of the company were up 2.

American Council on Science and Health4hOpinion

A Dangerous Gamble: The U.S. Abandons Bird Flu Vaccine Preparedness

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

4d

FDA expanding COVID vaccine warnings over rare heart side effect

The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...

Moderna, Merck, UroGen, Score RSV and Cancer Nods in June

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

1d

Stock Movers: Circle Falls, Disney Climbs, Moderna Meets Flu Shot Goal

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results